Aug 7 (Reuters) - The U.S. Food and Drug Administration on Thursday announced a new program to strengthen the domestic pharmaceutical supply chain, by facilitating the construction of manufacturing sites in the United States.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.